- Home
- PFGC vs MDGL Comparison
PFGC vs MDGL Comparison
Compare PFGC & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PFGC | MDGL |
|---|---|---|
| Founded | 1885 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Distributors | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.0B | 12.1B |
| IPO Year | 2014 | 2005 |
Fundamental Metrics
Financial Performance| Metric | PFGC | MDGL |
|---|---|---|
| Price | $87.37 | $517.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 12 |
| Target Price | $116.44 | ★ $674.45 |
| AVG Volume (30 Days) | ★ 1.6M | 261.6K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 41.32 |
| EPS | ★ 0.99 | N/A |
| Revenue | ★ $17,619,900,000.00 | $180,133,000.00 |
| Revenue This Year | $15.14 | $58.39 |
| Revenue Next Year | $6.61 | $48.55 |
| P/E Ratio | $89.01 | ★ N/A |
| Revenue Growth | ★ 5.12 | N/A |
| 52 Week Low | $77.44 | $265.00 |
| 52 Week High | $109.05 | $615.00 |
Technical Indicators
Market Signals| Indicator | PFGC | MDGL |
|---|---|---|
| Relative Strength Index (RSI) | 47.98 | 53.05 |
| Support Level | $82.02 | $503.93 |
| Resistance Level | $89.06 | $539.17 |
| Average True Range (ATR) | 2.46 | 16.12 |
| MACD | -0.08 | -3.62 |
| Stochastic Oscillator | 20.81 | 37.60 |
Price Performance
Historical ComparisonAbout PFGC Performance Food Group Company
Performance Food Group Co , markets and distributes national and company-branded food and food-related products. The company also specializes in distributing candy, snacks, beverages, cigarettes, other tobacco products, health and beauty care products and other items to vending distributors, box retailers, theaters, convenience stores, drug stores, grocery stores, travel providers, and hospitality providers. The company has three reportable segments: Foodservice, Vistar, and Convenience.
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.